Last reviewed · How we verify
NCT03057093: T-infarction
TIII Over TI in Subjects With Myocardial Infarction
trial testing Non interventional study in NSTEMI - Non-ST Segment Elevation MI in 903 participants. Completed in 15 January 2017.
30 September 2013
Quick facts
| Lead sponsor | University of Cologne |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 903 |
| Start date | 1 January 2011 |
| Primary completion | 30 September 2013 |
| Estimated completion | 15 January 2017 |
Drugs / interventions tested
- Non interventional study
Conditions studied
- NSTEMI - Non-ST Segment Elevation MI — all drugs for NSTEMI - Non-ST Segment Elevation MI →
Sponsor
University of Cologne
Who can join
Eligibility, any sex, with NSTEMI - Non-ST Segment Elevation MI. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study was performed to identify ECG criteria for unmasking of subjects with NSTEMI at elevated risk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03057093
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Non interventional study
Trials testing the same drug.
- NCT06906380 — A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies · not yet recruiting
- NCT06170671 — REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania · active not recruiting
- NCT05437250 — National Acalabrutinib Observational Study · active not recruiting
- NCT06749015 — A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) · recruiting
- NCT04590950 — Dosage and PD Study of Eftrenonacog-alfa · completed
Other recruiting trials for NSTEMI - Non-ST Segment Elevation MI
Currently open trials in the same condition.
- NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
- NCT06528821 — AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS · active not recruiting
- NCT07026708 — TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevat · recruiting
- NCT06384846 — AI Algorithms in Prediction of ACS Based on Leukocyte Properties · recruiting
- NCT04436978 — What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? · Phase 4 · recruiting
Other University of Cologne trials
Trials by the same sponsor.
- NCT07280585 — STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease · Phase 3 · recruiting
- NCT06612515 — Vaccine-induced Immunity in Immunocompromised Patients · recruiting
- NCT06781710 — Analysis of the Epidemiology, Clinical Presentation and Therapy as Well as Therapy-associated Risk of Demyelination Synd · recruiting
- NCT05969431 — Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study · recruiting
- NCT05876221 — Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03057093 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cologne
- Last refreshed: 17 February 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03057093.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing